GEP20125531B - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number
GEP20125531B
GEP20125531B GEAP200711224A GEAP2007011224A GEP20125531B GE P20125531 B GEP20125531 B GE P20125531B GE AP200711224 A GEAP200711224 A GE AP200711224A GE AP2007011224 A GEAP2007011224 A GE AP2007011224A GE P20125531 B GEP20125531 B GE P20125531B
Authority
GE
Georgia
Prior art keywords
surfactant
improved properties
reconstituted surfactants
reconstituted
native
Prior art date
Application number
GEAP200711224A
Other languages
English (en)
Inventor
Farmaceutici S P A Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20125531(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of GEP20125531B publication Critical patent/GEP20125531B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
GEAP200711224A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties GEP20125531B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
GEP20125531B true GEP20125531B (en) 2012-05-25

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP200711224A GEP20125531B (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Country Status (35)

Country Link
US (2) US8183210B2 (https=)
EP (1) EP2078038B1 (https=)
JP (2) JP5405307B2 (https=)
KR (1) KR101328851B1 (https=)
CN (2) CN101522711B (https=)
AR (2) AR063263A1 (https=)
AU (1) AU2007306075B2 (https=)
BR (1) BRPI0715317B1 (https=)
CA (1) CA2666344C (https=)
CL (1) CL2007002931A1 (https=)
CO (1) CO6400235A2 (https=)
CY (1) CY1114716T1 (https=)
DK (1) DK2078038T3 (https=)
EA (1) EA015802B1 (https=)
ES (1) ES2438727T3 (https=)
GE (1) GEP20125531B (https=)
HR (1) HRP20140052T1 (https=)
IL (1) IL198075A (https=)
JO (1) JO2963B1 (https=)
MA (1) MA31062B1 (https=)
ME (2) MEP12109A (https=)
MX (1) MX343064B (https=)
MY (1) MY148127A (https=)
NO (1) NO342038B1 (https=)
NZ (1) NZ576189A (https=)
PE (1) PE20081184A1 (https=)
PL (1) PL2078038T3 (https=)
PT (1) PT2078038E (https=)
RS (1) RS53172B (https=)
SI (1) SI2078038T1 (https=)
TN (1) TN2009000099A1 (https=)
TW (1) TWI388333B (https=)
UA (1) UA94477C2 (https=)
WO (1) WO2008044109A1 (https=)
ZA (1) ZA200902481B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
US9815869B2 (en) 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
AR093569A1 (es) 2012-11-21 2015-06-10 Chiesi Farm Spa Tensioactivos pulmonares reconstituidos
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
RU2748417C2 (ru) 2016-08-24 2021-05-25 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Стабильная фармацевтическая композиция, включающая восстановленную композицию легочного сурфактанта
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties
EP4228691A4 (en) * 2020-10-16 2025-01-01 Biosuperior Technology, Inc. PULMONARY TREATMENT COMPOSITIONS
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001164A1 (en) * 1993-06-30 1995-01-12 Genentech, Inc. Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2658478C (en) * 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
EP2078038B1 (en) 2013-11-20
HK1134497A1 (en) 2010-04-30
CY1114716T1 (el) 2016-10-05
US20100004173A1 (en) 2010-01-07
MEP12109A (en) 2011-12-20
CA2666344C (en) 2017-04-18
PE20081184A1 (es) 2008-09-26
MX343064B (es) 2016-10-24
AU2007306075B2 (en) 2012-08-09
DK2078038T3 (da) 2013-12-02
PL2078038T3 (pl) 2014-05-30
KR20090083892A (ko) 2009-08-04
PT2078038E (pt) 2013-12-12
CN101522711A (zh) 2009-09-02
BRPI0715317B1 (pt) 2021-10-05
AR113422A2 (es) 2020-04-29
ES2438727T3 (es) 2014-01-20
EA200900373A1 (ru) 2009-10-30
HRP20140052T1 (hr) 2014-02-28
US8183210B2 (en) 2012-05-22
AR063263A1 (es) 2009-01-14
NZ576189A (en) 2011-09-30
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
JP2013241449A (ja) 2013-12-05
JP5405307B2 (ja) 2014-02-05
CA2666344A1 (en) 2008-04-17
MX2009003638A (es) 2009-04-22
CN101522711B (zh) 2013-11-13
MA31062B1 (fr) 2010-01-04
CN103169947A (zh) 2013-06-26
HK1185274A1 (en) 2014-02-14
IL198075A0 (en) 2011-08-01
JP2010505937A (ja) 2010-02-25
KR101328851B1 (ko) 2013-11-14
JO2963B1 (en) 2016-03-15
WO2008044109A1 (en) 2008-04-17
ZA200902481B (en) 2010-07-28
TN2009000099A1 (en) 2010-08-19
NO20091441L (no) 2009-06-23
ME02326B (me) 2016-06-20
UA94477C2 (ru) 2011-05-10
AU2007306075A1 (en) 2008-04-17
RS53172B (sr) 2014-06-30
US9238058B2 (en) 2016-01-19
CL2007002931A1 (es) 2008-03-24
TW200824705A (en) 2008-06-16
TWI388333B (zh) 2013-03-11
EA015802B1 (ru) 2011-12-30
BRPI0715317A2 (pt) 2013-07-09
IL198075A (en) 2016-04-21
US20130079275A1 (en) 2013-03-28
NO342038B1 (no) 2018-03-19
MY148127A (en) 2013-02-28
EP2078038A1 (en) 2009-07-15
SI2078038T1 (sl) 2014-02-28

Similar Documents

Publication Publication Date Title
GEP20125531B (en) Reconstituted surfactants having improved properties
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
UA95235C2 (en) Glucagon-like-peptide-2 (glp-2) analogues
JO3226B1 (ar) مخفف توتر سطحي معاد التشكيل مطور يحتوي على نظائر بروتين مخفف للتوتر السطحي b(sp-b) وبروتين مخفف للتوتر السطحي c (sp-c)
WO2009010968A3 (en) Disease treatment via antimicrobial peptides or their inhibitors
WO2004074315A3 (en) Analogues of glp-1
BRPI0509903A (pt) uso de compostos peptìdicos para profilaxia e tratamento da cefaléia crÈnica
NO20080552L (no) GLP-1 farmasoytiske sammensetninger
EA201000161A1 (ru) Синтетические поверхностно-активные пептиды легких
SE0401631D0 (sv) New Composition
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides
AU2003251728A8 (en) Placental growth factor as a target for the treatment of osteoporosis
DE60118898D1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
WO2024173352A3 (en) Methods of treating cancer with a sirp1a-based chimeric protein
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2